Date | Title | Description |
20.12.2024 | ContextVision's Share Buyback: A Strategic Move in Medical Technology | ContextVision AB, a leader in medical imaging software, recently made headlines with its share buyback announcement. This strategic maneuver reflects a company confident in its future. The buyback, initially set for up to 3 million shares, ... |
18.12.2024 | Correction: ContextVision AB: Result of the offer to buy back own shares | Correction: ContextVision AB: Result of the offer to buy back own shares
Wed, Dec 18, 2024 11:55 CET Report this content
Stockholm, Dec 18, 2024
A correction is made to the press release published today, December 18, 2024, at 08.10 AM, rega... |
18.12.2024 | ContextVision AB: Result of the offer to buy back own shares | ContextVision AB: Result of the offer to buy back own shares
Wed, Dec 18, 2024 08:10 CET Report this content
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY IN UNITED STATES, CANADA, AUSTRALIA, JAPAN OR ANY JURISDICTION IN WHICH THE... |
16.12.2024 | Inify Laboratories: Key information regarding potential Subsequent Offering | Inify Laboratories: Key information regarding potential Subsequent Offering
Mon, Dec 16, 2024 08:05 CET Report this content
Reference is made to the stock exchange announcement published today, 16 December 2024, regarding the successful pri... |
13.12.2024 | ContextVision AB: Launch of offer to buy back own shares | ContextVision AB: Launch of offer to buy back own shares
Fri, Dec 13, 2024 08:30 CET Report this content
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY IN UNITED STATES, CANADA, AUSTRALIA, JAPAN OR ANY JURISDICTION IN WHICH THE DIS... |
12.12.2024 | Inify Laboratories and Stora Enso: A Tale of Growth and Returns | In the bustling world of finance, two companies stand out this December: Inify Laboratories and Stora Enso. Each is navigating its own path, driven by ambition and strategic decisions. Their recent announcements reveal much about their futu... |
09.12.2024 | Inify Laboratories announces application periods for fully guaranteed private placement and fully guaranteed subsequent repair issue | Inify Laboratories announces application periods for fully guaranteed private placement and fully guaranteed subsequent repair issue
Mon, Dec 09, 2024 12:04 CET Report this content
STOCKHOLM – 9 December 2024 – Reference is made to the stoc... |
06.12.2024 | Inify Laboratories AB (publ) - Bulletin from the extraordinary general meeting | Inify Laboratories AB (publ) - Bulletin from the extraordinary general meeting
Fri, Dec 06, 2024 12:00 CET Report this content
Today, December 6, 2024, INIFY Laboratories AB, org. no. 559345-4431 (the "Company") held an extraordin... |
25.11.2024 | Mandatory notification of trade – primary insider | Mandatory notification of trade – primary insider
Mon, Nov 25, 2024 16:30 CET Report this content
Martin Hedlund, member of the Board of ContextVision has purchased shares in ContextVision.
With reference to Section 4-2 of the Norwegian Sec... |
24.11.2024 | ContextVision's Strategic Moves: Insider Trades and Incentive Programs | In the world of finance, every move counts. ContextVision AB, a leader in medical technology, is making waves with recent insider trades and a new long-term incentive program. These actions reflect a strategic vision aimed at growth and sta... |
22.11.2024 | Mandatory notification of trade – primary insider | Mandatory notification of trade – primary insider
Fri, Nov 22, 2024 16:31 CET Report this content
Gerald Pötzsch, CEO of ContextVision, and Olof Sandén, Chairman of the Board of ContextVision has purchased shares in ContextVision.
With refe... |
20.11.2024 | BULLETIN FROM THE EXTRAORDINARY GENERAL MEETING OF CONTEXTVISION AB (PUBL) | BULLETIN FROM THE EXTRAORDINARY GENERAL MEETING OF CONTEXTVISION AB (PUBL)
Wed, Nov 20, 2024 12:05 CET Report this content
At the Extraordinary General Meeting of ContextVision AB (publ) held on November 20, 2024, the following decisions we... |
15.11.2024 | Inify Laboratories: A New Chapter in Cancer Diagnostics | In the world of healthcare, precision is paramount. Inify Laboratories, a Swedish company, is stepping into the spotlight with a bold vision for cancer diagnostics. As they prepare for an Extraordinary General Meeting (EGM) on December 6, 2... |
15.11.2024 | Inify Laboratories - notice of Extraordinary General Meeting on December 6, 2024 | Inify Laboratories - notice of Extraordinary General Meeting on December 6, 2024
Fri, Nov 15, 2024 12:00 CET Report this content
Stockholm – November 15, 2024 - Inify Laboratories AB (publ), a unique laboratory service provider within patho... |
15.11.2024 | Inify Laboratories: Notice of Extraordinary General Meeting and proposed fully guaranteed equity issue with proceeds of SEK 150 million | Inify Laboratories: Notice of Extraordinary General Meeting and proposed fully guaranteed equity issue with proceeds of SEK 150 million
Fri, Nov 15, 2024 12:00 CET Report this content
STOCKHOLM – November 15, 2024 – reference is made to the... |
10.11.2024 | ContextVision's Q3 2024 Report: Navigating Challenges and Charting a Path Forward | In the world of medical technology, ContextVision stands as a beacon of innovation. Their recent Q3 2024 report sheds light on both the challenges and opportunities that lie ahead. As the company maneuvers through a complex landscape, it fo... |
07.11.2024 | Q3 interim report 2024 – Focus on internal efficiency and product development to drive long-term growth | Q3 interim report 2024 – Focus on internal efficiency and product development to drive long-term growth
Thu, Nov 07, 2024 08:00 CET Report this content
Q3 Highlights Continuing integration with newly signed customers in Asia and North Ameri... |
07.11.2024 | ContextVision publishes Webcast for Q3 2024 | ContextVision publishes Webcast for Q3 2024
Thu, Nov 07, 2024 08:00 CET Report this content
Watch CEO Gerald Pötzsch and CFO Richard Hallström present ContextVision’s highlights from Q3 2024 along the financials for the quarter.
The Webcast... |
05.11.2024 | Inify Laboratories enter a research partnership with the Department of Molecular Medicine and Surgery at Karolinska Institutet aiming to advance precision diagnostics within prostate cancer | Inify Laboratories enter a research partnership with the Department of Molecular Medicine and Surgery at Karolinska Institutet aiming to advance precision diagnostics within prostate cancer
Tue, Nov 05, 2024 08:04 CET Report this content
ST... |
19.10.2024 | ContextVision's Extraordinary General Meeting: A Crucial Gathering for Shareholders | ContextVision AB is gearing up for an important event. On November 20, 2024, shareholders will gather for an Extraordinary General Meeting (EGM) in Stockholm. This meeting is not just a formality; it’s a pivotal moment for the company and i... |
18.10.2024 | Notice to the Extraordinary General Meeting in ContextVision AB (publ) | Notice to the Extraordinary General Meeting in ContextVision AB (publ)
Fri, Oct 18, 2024 17:00 CET Report this content
The shareholders of ContextVision AB (publ), reg. no. 556377-8900, are hereby invited to the Extraordinary General Meetin... |
10.10.2024 | Inify Laboratories gets honorable mention by the Royal Swedish Academy of Engineering Sciences (IVA) at the Smart Industry business competition 2024 | Inify Laboratories gets honorable mention by the Royal Swedish Academy of Engineering Sciences (IVA) at the Smart Industry business competition 2024
Thu, Oct 10, 2024 15:56 CET Report this content
STOCKHOLM - October 10, 2024 - Inify Labora... |
09.09.2024 | Panel talk about Inify’s second quarter 2024 | Panel talk about Inify’s second quarter 2024
Mon, Sep 09, 2024 12:08 CET Report this content
"We are saving weeks in waiting time for patients to get the diagnosis".
This and more value that Inify Laboratories can provide to its c... |
28.08.2024 | ContextVision AB: Navigating Challenges and Opportunities in Medical Imaging | ContextVision AB, a leader in medical imaging technology, recently released its Q2 2024 interim report. The numbers tell a story of resilience amid challenges. The company reported net sales of 31.7 million SEK, a decline of 6.2% from the p... |
26.08.2024 | ContextVision AB: Q2 interim report 2024 - Strong cash position supports continued investment in Image and Data Quality | ContextVision AB: Q2 interim report 2024 - Strong cash position supports continued investment in Image and Data Quality
Mon, Aug 26, 2024 08:00 CET Report this content
Q2 Highlights New customers signed in Asia and North America. ContextVis... |
26.08.2024 | ContextVision publishes Webcast for Q2 2024 | ContextVision publishes Webcast for Q2 2024
Mon, Aug 26, 2024 08:00 CET Report this content
Watch CEO Gerald Pötzsch and CFO Richard Hallström present ContextVision’s highlights from Q2 2024 along the financials for the quarter.
The Webcast... |
21.08.2024 | INIFY Laboratories: 62% revenue growth and strong international interest | INIFY Laboratories: 62% revenue growth and strong international interest
Wed, Aug 21, 2024 08:00 CET Report this content
STOCKHOLM - August 21, 2024 - Inify Laboratories, a unique laboratory service that provides cancer diagnostics within p... |
18.07.2024 | ContextVision enters Data Quality market with organ-specific enhancements | ContextVision enters Data Quality market with organ-specific enhancements
Thu, Jul 18, 2024 08:00 CET Report this content
Stockholm, Sweden, July 18, 2024 – ContextVision, a leading provider of medical image processing and analysis technolo... |
15.05.2024 | Inify Laboratories AB (publ) – summary of Annual General Meeting | Inify Laboratories AB (publ) – summary of Annual General Meeting
Wed, May 15, 2024 08:00 CET Report this content
Inify Laboratories AB, corp. no. 559345-4431, held its ordinary Shareholders’ Annual General Meeting at the company's premises ... |
14.05.2024 | ContextVision – Mandatory notification of trade – primary insider | ContextVision – Mandatory notification of trade – primary insider
Tue, May 14, 2024 16:00 CET Report this content
STOCKHOLM – May 14, 2024 – Gerald Pötzsch, CEO of ContextVision, has between May 8th and May 10th, 2024, purchased 10.000 shar... |
14.05.2024 | Bulletin from the Annual General Meeting of ContextVision AB (publ) on 14 May 2024 | Bulletin from the Annual General Meeting of ContextVision AB (publ) on 14 May 2024
Tue, May 14, 2024 15:30 CET Report this content
ContextVision (publ), org. no. 556377-8900 (the "Company"), held its Annual General Meeting on May ... |
08.05.2024 | ContextVision AB: Q1 interim report 2024 - Building for the future and leading innovation | ContextVision AB: Q1 interim report 2024 - Building for the future and leading innovation
Wed, May 08, 2024 08:00 CET Report this content
Q1 Highlights
Participation in the European Congress of Radiology in Vienna meeting new potential cust... |
08.05.2024 | ContextVision publishes Webcast for Q1 2024 | ContextVision publishes Webcast for Q1 2024
Wed, May 08, 2024 08:00 CET Report this content
Watch CEO Gerald Pötzsch and CFO Richard Hallström present ContextVision’s highlights from Q1 2024 along the financials for the quarter.
The Webcast... |
24.04.2024 | Inify Laboratories - More diagnoses delivered in the first quarter than in the whole of 2023 | Inify Laboratories - More diagnoses delivered in the first quarter than in the whole of 2023
Wed, Apr 24, 2024 08:00 CET Report this content
STOCKHOLM - April 24, 2024 - Inify Laboratories, a unique laboratory service provider within pathol... |
12.04.2024 | Notice to Attend the Annual General Meeting in ContextVision AB (publ) | Notice to Attend the Annual General Meeting in ContextVision AB (publ)
Fri, Apr 12, 2024 08:00 CET Report this content
The shareholders of ContextVision AB (publ), corporate identity number 556377-8900, are hereby invited to the Annual Gene... |
12.04.2024 | ContextVision publishes annual report for the fiscal year 2023 | ContextVision publishes annual report for the fiscal year 2023
Fri, Apr 12, 2024 08:00 CET Report this content
The annual report of ContextVision for the fiscal year 2023 is now available at www.contextvision.com. The annual report is a sum... |
11.04.2024 | Inify Laboratories - Annual Report 2023 | Inify Laboratories - Annual Report 2023
Thu, Apr 11, 2024 08:00 CET Report this content
Stockholm – April 11, 2024 – Inify Laboratories, a unique laboratory service provider within pathology and cancer diagnostics, presents its Annual Repor... |
11.04.2024 | Inify Laboratories – notice of Annual General Meeting on May 14, 2024 | Inify Laboratories – notice of Annual General Meeting on May 14, 2024
Thu, Apr 11, 2024 08:00 CET Report this content
Stockholm – April 11, 2024 – Inify Laboratories AB (publ), a unique laboratory service provider within pathology and cance... |
03.04.2024 | ContextVision Announces New Image Quality Advancements in X-Ray | ContextVision Announces New Image Quality Advancements in X-Ray
Wed, Apr 03, 2024 08:00 CET Report this content
STOCKHOLM, SWEDEN / April 2024 /
ContextVision, the global leader in image enhancement technology, will be presenting their late... |
29.02.2024 | Foresees a noticeable increase of customers, volume, and sales in 2024 | Foresees a noticeable increase of customers, volume, and sales in 2024
Thu, Feb 29, 2024 08:00 CET Report this content
STOCKHOLM - February 29, 2024 - Inify Laboratories, a unique laboratory service provider within pathology and cancer diag... |
16.02.2024 | ContextVision publishes Webcast for Q4 2023 | ContextVision publishes Webcast for Q4 2023
Fri, Feb 16, 2024 08:00 CET Report this content
Watch CEO Gerald Pötzsch and CFO Richard Hallström present ContextVision's highlights from Q4 2023 along the financials for the quarter and full yea... |
15.02.2024 | ContextVision AB: Year-end report 2023 – Underlying growth and scaling up the business | ContextVision AB: Year-end report 2023 – Underlying growth and scaling up the business
Thu, Feb 15, 2024 08:00 CET Report this content
Q4 Highlights New advanced X-ray product Altumira™ Plus with scatter correction released Participation in... |
26.10.2023 | RECORD TOPLINE GROWTH AND STRONG MARGINS | RECORD TOPLINE GROWTH AND STRONG MARGINS
Thu, Oct 26, 2023 08:00 CET Report this content
With a record revenue and a solid EBITDA margin of 44% in Q3 as well as the first nine months, the company reaffirms its foundation for growth. The str... |
27.04.2023 | Continued strong growth | Continued strong growth
Thu, Apr 27, 2023 08:00 CET Report this content
STOCKHOLM – April 27th, 2023 - ContextVision, a medical technology software company specializing in image processing and image analysis, today proudly presents their Q1... |
16.02.2023 | Strong Q4 and a record full year 2022 | Strong Q4 and a record full year 2022
Thu, Feb 16, 2023 08:00 CET Report this content
STOCKHOLM – Feb 16, 2023 – ContextVision, a medical technology software company specializing in image processing and image analysis, today reports its fou... |
02.11.2022 | ContextVision – Mandatory notification of trade – primary insider | ContextVision – Mandatory notification of trade – primary insider
Wed, Nov 02, 2022 11:30 CET Report this content
STOCKHOLM – November 02 2022 – Gerald Pötzsch, CEO of ContextVision, has during the period of August 31st until November 1st, ... |
26.10.2022 | ContextVision – Mandatory notification of trade – primary insider | ContextVision – Mandatory notification of trade – primary insider
Wed, Oct 26, 2022 13:28 CET Report this content
STOCKHOLM – October 26 2022 – Markus Hökerberg, CFO of ContextVision, has during October 20-26, 2022 purchased 11,600 shares i... |
11.08.2022 | ContextVision – Mandatory notification of trade – primary insider | ContextVision – Mandatory notification of trade – primary insider
Thu, Aug 11, 2022 10:37 CET Report this content
STOCKHOLM – August 11 2022 – Markus Hökerberg, CFO of ContextVision, has on August 11th, 2022 purchased 7,000 shares in Contex... |
11.08.2022 | Successfully focusing on core business | Successfully focusing on core business
Thu, Aug 11, 2022 08:00 CET Report this content
STOCKHOLM – 12 of August 2022 – ContextVision, a medical technology software company specializing in image processing, delivered the Company’s best ever ... |
14.02.2022 | ContextVision Announces New Leadership Team, Appoints Ola Lindblad as CEO | ContextVision Announces New Leadership Team, Appoints Ola Lindblad as CEO
Mon, Feb 14, 2022 17:21 CET Report this content
STOCKHOLM – February 14, 2022 – ContextVision, a medical technology software company specializing in image quality and... |
07.02.2022 | ContextVision confirms the value of the upcoming dividend | Stockholm, February 7th, 2022, in accordance with the regulations of the Oslo Stock Exchange.
ContextVision hereby confirms the value of the upcoming dividend.
In accordance with the information in the notice to the Extraordinary General Me... |
07.02.2022 | ContextVision confirms the value of the upcoming dividend | ContextVision confirms the value of the upcoming dividend
Mon, Feb 07, 2022 10:54 CET Report this content
Stockholm, February 7th, 2022, in accordance with the regulations of the Oslo Stock Exchange.
ContextVision hereby confirms the value ... |
20.01.2022 | ContextVision – new CFO appointed | ContextVision – new CFO appointed Thu, Jan 20, 2022 19:23 CET
Stockholm, January 12th, 2022 – ContextVision, the world’s leading Image enhancement provider is pleased to announce the appointment of Markus Hökerberg as an interim Chief Finan... |
10.12.2021 | INIFY Laboratories AB becomes an independent company | INIFY Laboratories AB becomes an independent company Fri, Dec 10, 2021 11:30 CET
STOCKHOLM – December 10, 2021 - ContextVision, a medical technology software company specializing in image processing, today announces that at the EGM of Conte... |
15.11.2021 | ContextVision to focus pathology efforts on the establishment of a fully AI-supported lab service | ContextVision to focus pathology efforts on the establishment of a fully AI-supported lab service Mon, Nov 15, 2021 12:25 CET
STOCKHOLM – Nov 15, 2021 - ContextVision, a medical technology software company specializing in image processing a... |